News

Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting

CRANBURY, N.J.--(BUSINESS WIRE)--Dec. 22, 2022-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company...

Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Rocket Pharmaceuticals Completes Acquisition of Renovacor

CRANBURY, N.J.--(BUSINESS WIRE)--Dec. 1, 2022-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company...

Broadview Ventures Appoints Cardiovascular Leader and Biotech Executive Michael Mendelsohn, MD to its Strategic Advisory Board

BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced...

Nyra Medical Announces $20 Million Series A Financing for its Transcatheter Heart Valve Repair Technology

ATLANTA, Nov. 23, 2022 /PRNewswire/ -- Nyra Medical, Inc., a medical device company that is...